Vikas Lifecare Limited (VIKASLIFE) AI Stock Analysis

Vikas Lifecare Limited

(NSE:VIKASLIFE)

Select Model

Rating:50Neutral

Price Target:INR 1.00▼(-9.91% Downside)

Action:reiterated

Date:08/27/26

Moderate score driven mainly by balance sheet stability and recent cash flow gains, tempered by earnings volatility, slowing growth, and weak valuation from ongoing losses.

Positive Factors

Revenue Scale-UpThe substantial expansion in revenue shows that Vikas Lifecare has increased its operating scale across polymer and chemical-related activities. A larger revenue base can support broader customer reach, improve commercial relevance, and provide a platform for future operating leverage if profitability stabilizes.

Negative Factors

Weak Operating ProfitabilityOperating losses and very thin gross margins indicate that revenue growth is not yet translating into durable operating earnings. Continued margin weakness could limit reinvestment capacity, weaken earnings quality, and make future results more sensitive to changes in costs and business mix.

Vikas Lifecare Limited (VIKASLIFE) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 2.06B
Dividend Yield: ―
Average Volume (3M): 447.09K
Price to Earnings (P/E): -1.5
Beta (1Y): 1.35
Revenue Growth: 4.03%
EPS Growth: -1217.25%
Country: India
Employees: 36
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Vikas Lifecare Limited Business Overview & Revenue Model

Company Description

Established in 1995 and headquartered in New Delhi, India, Vikas Lifecare Limited (which operated as Vikas Multicorp Limited until its name change in April 2021) is a multifaceted company with diverse operations. Its business is organized into Real E...

Vikas Lifecare Limited Financial Statement Overview

Summary

Mixed results with revenue growth slowing after early surges, inconsistent profitability, and low margins, offset by a stronger balance sheet with reduced leverage and a recent positive cash flow turnaround.

Income Statement

40Negative

Balance Sheet

75Positive

Cash Flow

50Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	4.99B	4.99B	4.80B	4.46B	4.76B	3.01B
Gross Profit	81.40M	55.92M	38.79M	262.04M	243.20M	101.59M
EBITDA	177.46M	195.84M	43.56M	240.93M	-160.56M	427.24M
Net Income	-1.11B	184.09M	-106.14M	140.29M	-152.99M	286.99M
Balance Sheet
Total Assets	7.60B	7.60B	7.29B	5.55B	4.55B	3.21B
Cash, Cash Equivalents and Short-Term Investments	10.80M	10.80M	431.74M	159.36M	113.13M	77.05M
Total Debt	1.05B	1.05B	767.00M	344.90M	304.07M	230.77M
Total Liabilities	2.09B	2.09B	1.96B	762.67M	1.21B	1.21B
Stockholders Equity	5.51B	5.51B	5.32B	4.77B	3.31B	1.99B
Cash Flow
Free Cash Flow	0	4.35B	-2.36B	-577.20M	-1.28B	-281.03M
Operating Cash Flow	0	4.36B	-2.24B	-417.48M	-1.10B	-148.84M
Investing Cash Flow	0	-4.67B	1.03B	-906.01M	-366.38M	-385.14M
Financing Cash Flow	0	261.45M	1.12B	1.37B	1.51B	590.87M

Vikas Lifecare Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price1.11

Price Trends

50DMA1.22Negative

100DMA1.29Negative

200DMA1.41Negative

Market Momentum

MACD-0.03Positive

RSI30.67Neutral

STOCH17.22Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIKASLIFE, the sentiment is Negative. The current price of 1.11 is below the 20-day moving average (MA) of 1.17, below the 50-day MA of 1.22, and below the 200-day MA of 1.41, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 30.67 is Neutral, neither overbought nor oversold. The STOCH value of 17.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VIKASLIFE.

Vikas Lifecare Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:VIKASLIFE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:AARTISURF	65Neutral	INR 3.96B	21.00	―	0.22%	25.22%	20.38%
IN:ROSSARI	65Neutral	INR 22.12B	14.48	―	0.13%	19.76%	11.74%
IN:AVTNPL	63Neutral	INR 13.38B	15.97	―	0.91%	40.77%	54.07%
IN:DYNPRO	61Neutral	INR 2.84B	14.01	―	0.66%	9.37%	25.43%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:VIKASLIFE	50Neutral	INR 2.06B	-1.54	―	―	4.03%	-1217.25%
IN:OAL	48Neutral	INR 19.29B	360.32	―	0.09%	13.55%	-77.69%

* General Sector Average

Performance Comparison

IN:VIKASLIFE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:VIKASLIFE	Vikas Lifecare Limited	1.11	-0.96	-46.38%
IN:AARTISURF	Aarti Surfactants Ltd.	467.55	-4.13	-0.88%
IN:AVTNPL	AVT Natural Products Limited	87.83	15.07	20.71%
IN:DYNPRO	Dynemic Products Limited	228.70	-72.38	-24.04%
IN:OAL	Oriental Aromatics Ltd.	573.20	226.95	65.55%
IN:ROSSARI	Rossari Biotech Ltd	399.25	-242.58	-37.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 27, 2026

Vikas Lifecare Limited AI Stock Analysis